Edwin Bremer reveals InnoCAR-T in exclusive Interview

In a recent interview conducted at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain, prof. dr. E. Bremer, the coordinator of UMCG, unveiled an innovative initiative poised to revolutionize CAR T-cell therapy. Prof. dr. E. Bremer explained that InnoCAR-T, is a doctoral network which brings together a consortium of ten candidates, three academic research institutes/universities, and two companies, all with the shared goal of propelling advancements in point-of-care CAR T-cell therapy. During the interview, prof. dr. E.Bremer provided valuable insights into the vision and objectives of InnoCAR-T. He highlighted the importance of bridging the gap between research and clinical practice, emphasizing the network's commitment to developing practical solutions that can benefit patients worldwide. Prof. dr.E. Bremer expressed optimism about the potential impact of InnoCAR-T, underscoring the significance of collaborative efforts in driving progress in CAR T-cell therapy.

Check out the full interview here